Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

Blue Origin's giant New Glenn rocket blasted off from Florida early Thursday morning on its first mission to space, an ...